Literature DB >> 8864123

Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice.

F P Lindberg1, D C Bullard, T E Caver, H D Gresham, A L Beaudet, E J Brown.   

Abstract

Granulocyte [polymorphonuclear leucocyte (PMN)] migration to sites of infection and subsequent activation is essential for host defense. Gene-targeted mice deficient for integrin-associated protein (IAP, also termed CD47) succumbed to Escherichia coli peritonitis at inoccula survived by heterozygous littermates. In vivo, they had an early defect in PMN accumulation at the site of infection. In vitro, IAP-/- PMNs were deficient in beta3 integrin-dependent ligand binding, activation of an oxidative burst, and Fc receptor-mediated phagocytosis. Thus, IAP plays a key role in host defense by participating both in PMN migration in response to bacterial infection and in PMN activation at extravascular sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864123     DOI: 10.1126/science.274.5288.795

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  117 in total

1.  Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF.

Authors:  M Fuortes; M Melchior; H Han; G J Lyon; C Nathan
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Macrophages as mediators of tumor immunosurveillance.

Authors:  Siddhartha Jaiswal; Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Trends Immunol       Date:  2010-05-07       Impact factor: 16.687

3.  Hoxa 11 is upstream of Integrin alpha8 expression in the developing kidney.

Authors:  M Todd Valerius; Larry T Patterson; Yuxin Feng; S Steven Potter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

4.  Role of the CD47-SHPS-1 system in regulation of cell migration.

Authors:  Sei-Ichiro Motegi; Hideki Okazawa; Hiroshi Ohnishi; Ryuji Sato; Yoriaki Kaneko; Hisae Kobayashi; Kyoko Tomizawa; Tomokazu Ito; Nakayuki Honma; Hans-Jörg Bühring; Osamu Ishikawa; Takashi Matozaki
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

5.  Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42.

Authors:  Motoaki Miyashita; Hiroshi Ohnishi; Hideki Okazawa; Hiroyasu Tomonaga; Akiko Hayashi; Tetsuro-Takahiro Fujimoto; Nobuhiko Furuya; Takashi Matozaki
Journal:  Mol Biol Cell       Date:  2004-06-23       Impact factor: 4.138

6.  Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice.

Authors:  F M Munoz; E P Hawkins; D C Bullard; A L Beaudet; S L Kaplan
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

7.  Increased Escherichia coli phagocytosis in neutrophils that have transmigrated across a cultured intestinal epithelium.

Authors:  P Hofman; M Piche; D F Far; G Le Negrate; E Selva; L Landraud; A Alliana-Schmid; P Boquet; B Rossi
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

8.  Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.

Authors:  Cecilia Koskinen; Emelie Persson; Paul Baldock; Åsa Stenberg; Ingrid Boström; Takashi Matozaki; Per-Arne Oldenborg; Pernilla Lundberg
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

9.  CD47 gene knockout protects against transient focal cerebral ischemia in mice.

Authors:  Guang Jin; Kiyoshi Tsuji; Changhong Xing; Yong-Guang Yang; Xiaoying Wang; Eng H Lo
Journal:  Exp Neurol       Date:  2009-02-20       Impact factor: 5.330

10.  Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells.

Authors:  Zhen Bian; Lei Shi; Ya-Lan Guo; Zhiyuan Lv; Cong Tang; Shuo Niu; Alexandra Tremblay; Mahathi Venkataramani; Courtney Culpepper; Limin Li; Zhen Zhou; Ahmed Mansour; Yongliang Zhang; Andrew Gewirtz; Koby Kidder; Ke Zen; Yuan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.